T. Joseph Raoof, MD, Inc.

Encino, California 94136

1 studies enrolling now · 12 studies all time

What they study most

Acne Vulgaris, Atopic Dermatitis, Atopic Dermatitis (AD), Crohn Disease, Onychomycosis, Plaque Psoriasis, Psoriasis, Rheumatoid Arthritis, Tinea Pedis

Studies at this site

• Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK) — Recruiting now
• A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis — Running, not enrolling
• A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis — Running, not enrolling
• A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2) — Running, not enrolling
• Natrunix or Placebo in Combination With Methotrexate in Rheumatoid Arthritis — Completed
• A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris — Completed
• A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis — Completed
• Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease — Stopped early
• DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis — Completed
• A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE) — Completed
• Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis — Completed
• Safety & Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails — Stopped early